TY - JOUR
T1 - Racial differences in genetic factors associated with breast cancer
AU - Ademuyiwa, Foluso O.
AU - Olopade, Olufunmilayo I.
PY - 2003/3
Y1 - 2003/3
N2 - Breast cancer in African Americans in the US is more aggressive and has a worse outcome than breast cancer in Caucasians. Although the incidence of breast cancer among US whites is higher than among blacks, the mortality rates for blacks are much higher. Breast cancer in blacks is also associated with a more advanced stage at presentation and pathologically aggressive tumors commonly exhibiting estrogen receptor negativity, higher S-phase fractions, and higher numbers of involved lymph nodes. This paper reviews some of the genetic factors that have been shown to be associated with a difference in breast cancer outcome between African Americans and Caucasians in the US such as the BRCA1 and BRCA2 genes, p53 mutations, UGT1A1 gene polymorphisms, and HER-2/neu gene amplifications/overexpression.
AB - Breast cancer in African Americans in the US is more aggressive and has a worse outcome than breast cancer in Caucasians. Although the incidence of breast cancer among US whites is higher than among blacks, the mortality rates for blacks are much higher. Breast cancer in blacks is also associated with a more advanced stage at presentation and pathologically aggressive tumors commonly exhibiting estrogen receptor negativity, higher S-phase fractions, and higher numbers of involved lymph nodes. This paper reviews some of the genetic factors that have been shown to be associated with a difference in breast cancer outcome between African Americans and Caucasians in the US such as the BRCA1 and BRCA2 genes, p53 mutations, UGT1A1 gene polymorphisms, and HER-2/neu gene amplifications/overexpression.
KW - African American
KW - Breast cancer
KW - Caucasian
KW - Genetic differences
UR - http://www.scopus.com/inward/record.url?scp=0037346703&partnerID=8YFLogxK
U2 - 10.1023/A:1022259901319
DO - 10.1023/A:1022259901319
M3 - Review article
C2 - 12716036
AN - SCOPUS:0037346703
SN - 0167-7659
VL - 22
SP - 47
EP - 53
JO - Cancer and Metastasis Reviews
JF - Cancer and Metastasis Reviews
IS - 1
ER -